Announcement on Implementation Result of Shares Repurchase and Share Changes
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Implementation Result of Shares Repurchase and Share Changes
Filed with SSE ·
On 6ix: 6ix.com/news/announcement-on-implementation-result-of-shares-repurchase-and-share-changes-109
6ix hasn’t read this filing yet.
BrightGene Bio-Medical Technology Co. Ltd. on 6ix
Earlier from BrightGene Bio-Medical Technology
- Announcement on Progress in Repurchasing Shares
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Waiver of the Preemptive Right for Capital Increase and Stock Expansion of Joint-stock Company and Related Party Transactions
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of BGM1812 Injection
- Announcement on Initially Repurchasing the Company's Shares through Call Auction
Later from BrightGene Bio-Medical Technology
- Announcement on Interest Payment for "BrightGene Convertible Bonds" in 2025
- Announcement on Postponing Investment Projects Financed by Raised Funds
- Announcement on Not Redeeming ""BrightGene Convertible Bonds"" in Advance
- Earnings Preannouncement for 2025
- Announcement on Voluntary Disclosure of the Proposed Selection of Partial Products in the National Continuation Drug Procurement
Follow BrightGene Bio-Medical Technology into a list and get an email when it puts out news.
Follow BrightGene Bio-Medical Technology